Correlation Between Sellas Life and Summit Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sellas Life and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sellas Life and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sellas Life Sciences and Summit Therapeutics PLC, you can compare the effects of market volatilities on Sellas Life and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sellas Life with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sellas Life and Summit Therapeutics.

Diversification Opportunities for Sellas Life and Summit Therapeutics

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Sellas and Summit is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Sellas Life Sciences and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and Sellas Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sellas Life Sciences are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of Sellas Life i.e., Sellas Life and Summit Therapeutics go up and down completely randomly.

Pair Corralation between Sellas Life and Summit Therapeutics

Considering the 90-day investment horizon Sellas Life Sciences is expected to generate 2.01 times more return on investment than Summit Therapeutics. However, Sellas Life is 2.01 times more volatile than Summit Therapeutics PLC. It trades about 0.19 of its potential returns per unit of risk. Summit Therapeutics PLC is currently generating about 0.14 per unit of risk. If you would invest  106.00  in Sellas Life Sciences on November 5, 2024 and sell it today you would earn a total of  42.00  from holding Sellas Life Sciences or generate 39.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sellas Life Sciences  vs.  Summit Therapeutics PLC

 Performance 
       Timeline  
Sellas Life Sciences 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sellas Life Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Sellas Life unveiled solid returns over the last few months and may actually be approaching a breakup point.
Summit Therapeutics PLC 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Summit Therapeutics PLC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable primary indicators, Summit Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Sellas Life and Summit Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sellas Life and Summit Therapeutics

The main advantage of trading using opposite Sellas Life and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sellas Life position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.
The idea behind Sellas Life Sciences and Summit Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals